Zhao Qu, Li Zeping, Wang Dao Wen, Li Fan, Zhang Li, Jiang Jiangang
Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, 430030, People's Republic of China.
Int J Gen Med. 2025 Mar 6;18:1333-1344. doi: 10.2147/IJGM.S509291. eCollection 2025.
Fulminant myocarditis (FM) is a critical manifestation of myocarditis. However, the clinical features and risk factors associated with its adverse outcomes are not fully understood. Given the high mortality and potential for long-term complications, it is crucial to identify factors that could predict the progression of FM to chronic persistent myocarditis. We hypothesize some clinical or laboratory markers may be predictive of this progression. This study aims to identify clinical factors that may help predict the progress of FM to chronic persistent myocarditis.
A total of 82 patients with FM treated based on Chinese protocol were included. Kaplan-Meier curve and regression analysis were used to determine the clinical features and prognostic predictors of chronic persistent myocarditis in patients with 24 months of follow-up.
Chronic persistent myocarditis was observed in 20 patients during the follow-up. ROC curve showed that the critical value for chronic persistent myocarditis caused by lactate dehydrogenase (LDH) was 577.00U/L (sensitivity 75.0%, specificity 74.2%). Time from onset to admission over 6 days and LDH > 577.00U/L were identified as risk factors for chronic persistent myocarditis in patients with FM in both univariate and multivariate cox analysis. The hazard ratio and 95% Confidence intervals were 3.35 (1.32-8.50) (p = 0.011) and 6.11 (2.02-18.48) ( < 0.001), respectively. The per standard deviation of increment in LDH was associated with the 55% (1.55, 1.11-2.18) in HR and 95% CI of the occurrence of chronic persistent myocarditis.
About 24.4% of the patients with FM treated based on the life support measures proposed in the consensus of Chinese Society of Cardiology have been observed chronic persistent myocarditis. Time from onset to admission over 6 days and LDH levels >577.00 U/L at admission may serve as risk factors for the progression from FM to chronic persistent myocarditis.
暴发性心肌炎(FM)是心肌炎的一种严重表现形式。然而,其不良预后相关的临床特征和危险因素尚未完全明确。鉴于其高死亡率和长期并发症的可能性,识别可预测FM进展为慢性持续性心肌炎的因素至关重要。我们推测一些临床或实验室指标可能可预测这种进展。本研究旨在识别可能有助于预测FM进展为慢性持续性心肌炎的临床因素。
纳入82例按照中国方案治疗的FM患者。采用Kaplan-Meier曲线和回归分析来确定随访24个月患者慢性持续性心肌炎的临床特征和预后预测因素。
随访期间20例患者出现慢性持续性心肌炎。ROC曲线显示,乳酸脱氢酶(LDH)导致慢性持续性心肌炎的临界值为577.00U/L(敏感性75.0%,特异性74.2%)。单因素和多因素cox分析均显示,发病至入院时间超过6天以及LDH>577.00U/L是FM患者慢性持续性心肌炎的危险因素。风险比和95%置信区间分别为3.35(1.32 - 8.50)(p = 0.011)和6.11(2.02 - 18.48)(<0.001)。LDH每增加一个标准差与慢性持续性心肌炎发生的HR增加55%(1.55,1.11 - 2.18)及95%CI相关。
按照中国心脏学会共识提出的生命支持措施治疗的FM患者中,约24.4%出现慢性持续性心肌炎。发病至入院时间超过6天以及入院时LDH水平>577.00 U/L可能作为FM进展为慢性持续性心肌炎的危险因素。